{"classes":[{"categories":[{"measurements":[{"comment":"Upper 95% confidence interval was not reached.","groupId":"OG000","lowerLimit":"52.4","upperLimit":"NA","value":"95.8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"54"}],"units":"Participants"}],"description":"Estimated using the product-limit method of Kaplan and Meier. Event defined as death due to any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"See Detailed Description\n\ntotal marrow irradiation: Undergo irradiation escalating according to the following schedule 1000cGy, 1200cGy, 1400cGy, 1600cGy, 1800cGy\n\nmelphalan: Given IV\n\nperipheral blood stem cell transplantation: Undergo transplantation\n\nfilgrastim: Given IV\n\nfluorescence in situ hybridization: Correlative studies\n\ncytogenetic analysis: Correlative studies\n\ncyclophosphamide: Given IV\n\nautologous-autologous tandem hematopoietic stem cell transplantation: Undergo transplantation\n\nlenalidomide: Given orally","id":"OG000","title":"Treatment Arm"}],"paramType":"MEDIAN","populationDescription":"Overall survival was calculated for aggregated arms, due to small number of patients in most treatment arms.","reportingStatus":"POSTED","timeFrame":"From date of treatment until the date of death from any cause, assessed up to 14 years","title":"Overall Survival","type":"PRIMARY","unitOfMeasure":"months"}